This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/12/2024
Operator
Conference Call Operator
Good afternoon and welcome to the Eaton Pharmaceuticals 3rd Quarter 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode. Following the formal remarks, we will open the call app for your questions. Please be advised that this call is being recorded at the company's request. At this time, I would like to turn it over to David Krempa. Chief Business Officer at Eaton Pharmaceuticals.
David Krempa
Chief Business Officer
Please proceed.
James Gruber
Chief Financial Officer
Thank you, Operator.
You're reading a preview of the ETON Q3 2024 earnings call.
Free account.
Disclaimer